The pain of antisense: in vivo application of antisense oligonucleotides for functional genomics in pain and analgesia. (Q35205482)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12935946%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

The pain of antisense: in vivo application of antisense oligonucleotides for functional genomics in pain and analgesia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12935946%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12935946%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Laura S Stone

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12935946%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12935946%20AND%20SRC:MED&resulttype=core&format=json

Advanced Drug Delivery Reviews

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12935946%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12935946%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12935946%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1081-1112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12935946%20AND%20SRC:MED&resulttype=core&format=json

Cell damage excites nociceptors through release of cytosolic ATP.

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

P2X receptors in peripheral neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Painful connection for ATP.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

A P2X purinoceptor expressed by a subset of sensory neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Distinct ATP receptors on pain-sensing and stretch-sensing neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

P2X3 is expressed by DRG neurons that terminate in inner lamina II

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

The expression of P2X3 purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Functional downregulation of P2X3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Analgesic profile of intrathecal P2X(3) antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Na+ channel immunolocalization in peripheral mammalian axons and changes following nerve injury and neuroma formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Ion channels of nociception.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Distribution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Redistribution of Na(V)1.8 in uninjured axons enables neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

The involvement of the tetrodotoxin-resistant sodium channel Na(v)1.8 (PN3/SNS) in a rat model of visceral pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antinociceptive effects after intrathecal administration of phosphodiester-, 2'-O-allyl-, and C-5-propyne-modified antisense oligodeoxynucleotides targeting the NMDAR1 subunit in mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antisense oligonucleotides to N-methyl-D-aspartate receptor subunits attenuate formalin-induced nociception in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Reduced nicotinic receptor-mediated antinociception following in vivo antisense knock-down in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Role of potassium channels in the antinociception induced by agonists of alpha2-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

The role of potassium channels in antihistamine analgesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Differential knockdown of delta-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antisense oligodeoxynucleotide to a delta-opioid receptor blocks the antinociception induced by cold water swimming

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antisense oligodeoxynucleotide to delta opioid receptors attenuates morphine dependence in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

kappa -opioid receptor agonists modulate visceral nociception at a novel, peripheral site of action

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antisense oligodeoxynucleotide targeting distinct exons of the cloned mu-opioid receptor distinguish between endomorphin-1 and morphine supraspinal antinociception in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of mu-opioid receptor clone leads to differential loss of spinal endomorphin-1-and endomorphin-2-induced antinociception in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Anatomical and functional correlation of the endomorphins with mu opioid receptor splice variants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Pharmacological characterization of morphine-6-sulfate and codeine-6-sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Effect of antisense knock-down of alpha(2a)- and alpha(2c)-adrenoceptors on the antinociceptive action of clonidine on trigeminal nociception in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antisense ablation of type I metabotropic glutamate receptor mGluR1 inhibits spinal nociceptive transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Knockdown of spinal metabotropic glutamate receptor 1 (mGluR(1)) alleviates pain and restores opioid efficacy after nerve injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antisense oligonucleotide knockdown of mGluR1 alleviates hyperalgesia and allodynia associated with chronic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Attenuation of morphine tolerance after antisense oligonucleotide knock-down of spinal mGluR1.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Intrathecal administration of PNA targeting galanin receptor reduces galanin-mediated inhibitory effect in the rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antisense oligodeoxynucleotide to the CCKB receptor produces naltrindole- and [Leu5]enkephalin antiserum-sensitive enhancement of morphine antinociception

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Loss of muscarinic antinociception by antisense inhibition of M(1) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antisense 'knockdowns' of M1 receptors induces transient anterograde amnesia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Intraperitoneal injection of antisense peptide nucleic acids targeted to the mu receptor decreases response to morphine and receptor protein levels in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

'Knock-down' of spinal CB1 receptors produces abnormal pain and elevates spinal dynorphin content in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociception.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

G-protein antisense oligodeoxyribonucleotides and mu-opioid supraspinal antinociception

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Differential effects of antisense oligodeoxynucleotides directed against g(zalpha) and g(oalpha) on antinociception produced by spinal opioid and alpha(2) adrenergic receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

G proteins and opioid receptor-mediated signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

In vivo modulation of G proteins and opioid receptor function by antisense oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

The role of the G protein gamma(2) subunit in opioid antinociception in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Knockdown of spinal opioid receptors by antisense targeting beta-arrestin reduces morphine tolerance and allodynia in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Neurotrophin-3 antisense oligonucleotide attenuates nerve injury-induced Abeta-fibre sprouting.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Inhibition of carrageenan-induced spinal c-Fos activation by systemically administered c-fos antisense oligodeoxynucleotides may be facilitated by local opening of the blood-spinal cord barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Properties of cloned and expressed human RNase H1.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

The involvement of human ribonucleases H1 and H2 in the variation of response of cells to antisense phosphorothioate oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Modification of phosphorothioate oligonucleotides yields potent analogs with minimal toxicity for antisense experiments in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Fully modified 2' MOE oligonucleotides redirect polyadenylation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-alpha chain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

RNA interference in adult mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Virally mediated delivery of enkephalin and other neuropeptide transgenes in experimental pain models

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Effects of RNA secondary structure on cellular antisense activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

The experimental use of antisense oligonucleotides: a guide for the perplexed

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

A good antisense molecule is hard to find

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Selection of effective antisense oligodeoxynucleotides with a green fluorescent protein-based assay

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Tetranucleotide GGGA motif in primary RNA transcripts. Novel target site for antisense design

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Phase I trial of ISIS 104838, a 2'-methoxyethyl modified antisense oligonucleotide targeting tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

RNA accessibility prediction: a theoretical approach is consistent with experimental studies in cell extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Theoretical and experimental approaches to design effective antisense oligonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Concepts to automate the theoretical design of effective antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

RNA mapping: selection of potent oligonucleotide sequences for antisense experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

A selection system for identifying accessible sites in target RNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Selecting effective antisense reagents on combinatorial oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Identification of sequence motifs in oligonucleotides whose presence is correlated with antisense activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Artificial neural network prediction of antisense oligodeoxynucleotide activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

ODNBase--a web database for antisense oligonucleotide effectiveness studies. Oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Sequence-specific interaction of alpha-beta-anomeric double-stranded DNA with the p50 subunit of NF kappa B: application to the decoy approach

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Specificity of antisense oligonucleotides in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Peripheral nerve injury alters the alpha2 adrenoceptor subtype activated by clonidine for analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Voltage-gated sodium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antisense suppression of GABA(A) receptor beta subunit levels in cultured cerebellar granule neurons demonstrates their importance in receptor expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Modulation of the gene expression of N-methyl-D-aspartate receptor NR2B subunit in the rat neostriatum by a single dose of specific antisense oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

The DRASIC cation channel contributes to the detection of cutaneous touch and acid stimuli in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Genomic interrogation of mechanism(s) underlying cellular responses to toxicants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Evaluating the specificity of antisense oligonucleotide conjugates. A DNA array analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antisense DNAs as multisite genomic modulators identified by DNA microarray

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Differential effects of intrastriatally infused fully and endcap phosphorothioate antisense oligonucleotides on morphology, histochemistry and prodynorphin expression in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Centrally administered oligodeoxynucleotides in rats: occurrence of non-specific effects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Potent and nontoxic antisense oligonucleotides containing locked nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antisense properties of peptide nucleic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Systemically delivered antisense oligomers upregulate gene expression in mouse tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Design of antisense oligonucleotides stabilized by locked nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

A short phosphodiester window is sufficient to direct RNase H-dependent RNA cleavage by antisense peptide nucleic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Formation of a G-tetrad and higher order structures correlates with biological activity of the RelA (NF-kappaB p65) 'antisense' oligodeoxynucleotide.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Specific inhibition of the rat ligand-gated ion channel P2X3 function via methoxyethoxy-modified phosphorothioated antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

The spread and uptake pattern of intracerebrally administered oligonucleotides in nerve and glial cell populations of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Intrastriatal and intraventricular injections of oligodeoxynucleotides in the rat brain: tissue penetration, intracellular distribution and c-fos antisense effects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Cellular uptake of intracerebroventricularly administered biotin- or digoxigenin-labeled antisense oligodeoxynucleotides in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Antisense imaging of gene expression in the brain in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Drug delivery of antisense molecules to the brain for treatment of Alzheimer's disease and cerebral AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Transdermal use of phosphorodiamidate morpholino oligomer AVI-4472 inhibits cytochrome P450 3A2 activity in male rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Chronic catheterization of the spinal subarachnoid space

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Intrathecal morphine in mice: a new technique

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Chronic intrathecal infusions after spinal cord injury cause scarring and compression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Lumbar catheterization of the spinal subarachnoid space in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Covalent Protein−Oligonucleotide Conjugates for Efficient Delivery of Antisense Molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Peptide-oligonucleotide phosphorothioate conjugates with membrane translocation and nuclear localization properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Elevated messenger RNA levels after antisense oligodeoxynucleotide treatment in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Inhibition of spinal protein kinase Calpha expression by an antisense oligonucleotide attenuates morphine infusion-induced tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Selective blockade of peripheral delta opioid agonist induced antinociception by intrathecal administration of delta receptor antisense oligodeoxynucleotide.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

The presence and role of the tetrodotoxin-resistant sodium channel Na(v)1.9 (NaN) in nociceptive primary afferent neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Quantitative real-time RT-PCR using hybridization probes and imported standard curves for cytokine gene expression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Peptide nucleic acid antisense prolongs skin allograft survival by means of blockade of CXCR3 expression directing T cells into graft.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Advances in proteome analysis by mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Advances in proteome analysis by mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

Direct analysis of protein complexes using mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

The application of mass spectrometry to membrane proteomics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900105-4

7 January 2021

10.1016/S0169-409X(03)00105-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12935946%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference